DrugPatentWatch Database Preview
Drugs in Development Information for Givinostat
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the drug development status for Givinostat?
Givinostat is an investigational drug.
There have been 8 clinical trials for Givinostat.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2016.
The most common disease conditions in clinical trials are Muscular Dystrophy, Duchenne, Muscular Dystrophies, and Polycythemia. The leading clinical trial sponsors are Italfarmaco, inVentiv Health Clinical, and Parexel.
There are seven US patents protecting this investigational drug and fifty-nine international patents.
Summary for Givinostat
| US Patents | 7 |
| International Patents | 59 |
| US Patent Applications | 14 |
| WIPO Patent Applications | 12 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2016-10-01) |
| Vendors | 19 |
Recent Clinical Trials for Givinostat
| Title | Sponsor | Phase |
|---|---|---|
| Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Becker Muscular Dystrophy | Italfarmaco | Phase 2 |
| Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy | inVentiv Health Clinical | Phase 3 |
| Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy | Italfarmaco | Phase 3 |
Clinical Trial Summary for Givinostat
Top disease conditions for Givinostat
Top clinical trial sponsors for Givinostat
US Patents for Givinostat
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Givinostat | Start Trial | Monohydrate hydrochloride of the 4-hydroxycarbamoyl-phenyl)-carbamic acid (6-diethylaminomethyl-naphtalen-2-yl) ester | Italfarmaco SpA (Milano, IT) | Start Trial |
| Givinostat | Start Trial | Method for treating Philadelphia-negative myeloproliferative syndromes | Italfarmaco SpA (Milan, IT) | Start Trial |
| Givinostat | Start Trial | Polymorph of the hydrochloride of the (4-hydroxycarbamoyl-phenyl)-carbamic acid (6-dimethylamino methyl-2-naphthalenyl) ester | Chemi SPA (Cinisello Balsamo, IT) | Start Trial |
| Givinostat | Start Trial | Thioxanthone-based autophagy inhibitor therapies to treat cancer | Spectrum Pharmaceuticals, Inc. (Irvine, CA) | Start Trial |
| Givinostat | Start Trial | Derivatives of N-hydroxybenzamide for treating HIV infections | Italfarmaco S.p.A. (Milan, IT) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Givinostat
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Givinostat | European Patent Office | 1583737 | 2023-01-17 | Start Trial |
| Givinostat | Spain | 2372280 | 2023-01-17 | Start Trial |
| Givinostat | Italy | MI20030063 | 2023-01-17 | Start Trial |
| Givinostat | Japan | 2006515028 | 2023-01-17 | Start Trial |
| Givinostat | Japan | 4425906 | 2023-01-17 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
